Stocks / PRME
Stock profile · 銘柄

Prime Medicine, Inc. - Common Stock (PRME)

Prime Medicine, Inc. - Common Stock (PRME) last closed at $4.23 (as of 2026-07-09). On Shishin's four-engine momentum model it scored 68/100, flagged by the Suzaku engine (Extended) on its most recent scan appearance (2026-07-09). It has surfaced in 1 daily scan since 2026-07-09. The figures below are research data, the Shishin Score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects PRME's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Shishin Score68
Active engineSuzaku
SetupExtended
Current close$4.23
SectorBiotechnology
Price · last ~60 sessions
$4.623/64/177/9
Indicators · as of 2026-07-09
ADR · 20d9.0%
ATR · 147.5%
RSI · 1477
Return · 30d+56%
Return · 60d+35%
Above MA2037%
Above MA5040%
Range · 20d81%
MA stack3
From 52w high-33%
$ Vol · 30d$14M
Vol ratio3.48×
Frequently asked

What is PRME's Shishin momentum score?

As of 2026-07-09, PRME scores 68/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is PRME showing a momentum setup?

PRME's current setup state is "Extended." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags PRME?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has PRME appeared in Shishin scans?

PRME has appeared in 1 daily scan since 2026-07-09. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin Score calculated?

The Shishin Score (0 to 100) is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →